Me-Check
We believe that screening for meibomian gland dysfunction (i.e., MGD) and other ocular surface pathologies should not be difficult or expensive for both operators and patients. That’s why we invested in developing a diagnostic and screening device that can tackle this challenge simply, quickly and effectively—me-check®.
